Acthar (repository Corticotropin ) 400 Units recalls
The FDA has published 1 recall involving Acthar (repository Corticotropin ) 400 Units since 2024. The latest was reported on 28 Feb 2024. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2024
Last 12 months0reported
Class I00% of total
Ongoing1latest 28 Feb 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why acthar (repository corticotropin ) 400 units is recalled
Companies
By year
Ongoing acthar (repository corticotropin ) 400 units recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Acthar Gel (repository corticotropin injection) recalled | Mallinckrodt Hospital Products | Manufacturing (CGMP) Deviations | Nationwide |
All acthar (repository corticotropin ) 400 units recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Acthar Gel (repository corticotropin injection) recalled | Mallinckrodt Hospital Products | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Acthar (repository Corticotropin ) 400 Units?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.